GlobeNewswire Inc.··NaCG Oncology's Bladder Cancer Therapy Shows Promising 92% Response Rate in Phase 2
CG Oncology reports strong Phase 2 results for bladder cancer combination therapy, achieving up to 92% complete response rates with favorable safety profile.
CGONbladder cancerphase 2 trial